… combination with sodium-glucose co-transporter 2 inhibitors or in post-myocardial infarction
HF. … , a wider and earlier use of S/V in the management of HF patients should be considered. …

… heart failure. Little is known on the impact of Sacubitril/Valsartan in hypertensive patients early
post myocardial … 1 week prior to and post myocardial infarction. ARNI and ARB restore the …

… Post-myocardial infarction heart failure (post-MI HF) is a common, life-threatening complication
in patients … All data in this study were used to determine the means and SDs. Student's t …

… HF and post-MI trials of sacubitril-valsartan. Similarly, multiple trials of early and aggressive
use of therapies effective in chronic heart failure immediately post-MI failed to demonstrate …

… “Sacubitril/valsartan compared to ramipril in high-risk post myocardial infarction patients
stratified according to use of mineralocorticoid receptor antagonists: Insight from PARADISE MI …

… the efficacy of sacubitril/valsartan over angiotensin-converting enzyme … of heart failure (HF)
in post-MI patients and providing a clear evidence-based medicine guideline for future use. …

… be used to stratify individuals at risk for remodelling, a patient … In PROVE-HF, sacubitril/valsartan
in HFrEF patients led to … in patients at risk for heart failure after myocardial infarction in …

… infarction are at a high risk of developing heart failure. The … sacubitril/valsartan 97/103 mg
twice daily with valsartan 160 … A strength of the present trial was the use of valsartan as the …

… in post-myocardial infarction (MI) and heart failure (HF… infarct size reduction with treatment
could be due to different species, ischemic procedure and techniques used to calculate infarct …

… In 147 contrast, two drugs (sacubitril-valsartan and losartan) were compared against active
controls in 148 both HFrEF and post-MI. Of note, only sacubitril-valsartan used two distinct …